Aya Mohamed, Medical Oncologist, Associate Lecturer of Medical Oncology, Member of ASCO, shared a post on X:
“ETHAN Trial | Advancing Care for Male Breast Cancer
The ETHAN study from Dana-Farber’s Breast Oncology Center is a pivotal Phase II trial evaluating multiple neoadjuvant endocrine therapy options in men with ER+/HER2– breast cancer a population long understudied.”
More posts featuring Aya Mohamed on OncoDaily.